Belite Bio FY2028 EPS Estimate Reduced by Leerink Partnrs
Belite Bio, Inc (NASDAQ:BLTE – Free Report) – Investment analysts at Leerink Partnrs decreased their FY2028 EPS estimates for Belite Bio in a report issued on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now expects that the company will earn $4.40 per share for the year, down from their prior forecast of $4.60. The […]
Belite Bio, Inc (NASDAQ:BLTE – Free Report) – Investment analysts at Leerink Partnrs decreased their FY2028 EPS estimates for Belite Bio in a report issued on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now expects that the company will earn $4.40 per share for the year, down from their prior forecast of $4.60. The […]
